First Header Logo Second Header Logo

Ruth Lininger

Concepts (203)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
5
2007
34
0.910
Why?
Breast Neoplasms
12
2016
666
0.710
Why?
Loss of Heterozygosity
4
2004
17
0.590
Why?
Endometrium
7
2009
120
0.460
Why?
Carcinoma in Situ
5
1999
13
0.410
Why?
Chromosomes, Human, Pair 16
2
1999
15
0.350
Why?
Endometrial Hyperplasia
2
2007
14
0.340
Why?
Carcinoma, Squamous Cell
3
2003
142
0.330
Why?
Carcinosarcoma
2
2005
3
0.310
Why?
Carcinoma, Ductal, Breast
5
1999
28
0.310
Why?
Carcinoma, Transitional Cell
2
1998
65
0.300
Why?
Protein-Tyrosine Kinases
2
2004
37
0.300
Why?
Estrogen Receptor alpha
1
2006
50
0.280
Why?
Receptor, erbB-2
1
2005
45
0.270
Why?
Uterus
1
2006
73
0.270
Why?
Endometriosis
1
2006
66
0.260
Why?
Carcinoma, Endometrioid
1
2004
4
0.260
Why?
Apocrine Glands
2
2002
2
0.240
Why?
Sweat Gland Neoplasms
2
2002
5
0.240
Why?
Female
27
2016
18112
0.230
Why?
Genes, Tumor Suppressor
2
1999
36
0.220
Why?
Uterine Cervical Neoplasms
2
2003
32
0.220
Why?
Ovarian Neoplasms
2
2000
87
0.210
Why?
Papillomaviridae
2
1998
17
0.200
Why?
Humans
29
2016
28998
0.190
Why?
CA-125 Antigen
1
2000
6
0.180
Why?
Chromosomes, Human, Pair 17
1
1999
11
0.180
Why?
Hemangioma
1
2000
18
0.180
Why?
Adnexal Diseases
1
2000
6
0.180
Why?
Polycystic Ovary Syndrome
3
2007
19
0.180
Why?
Chromosomes, Human, Pair 3
1
1999
28
0.180
Why?
Chromosomes, Human, Pair 1
1
1999
35
0.180
Why?
Carcinoma, Papillary
2
1998
13
0.180
Why?
Polymerase Chain Reaction
5
1999
172
0.180
Why?
Leuprolide
2
2009
8
0.170
Why?
Luteal Phase
2
2009
22
0.170
Why?
Papilloma, Intraductal
1
1998
2
0.170
Why?
Estradiol
3
2009
118
0.170
Why?
Vulvar Neoplasms
2
2002
6
0.150
Why?
G-Protein-Coupled Receptor Kinase 3
1
2016
2
0.140
Why?
Progesterone
2
2008
80
0.140
Why?
DNA, Neoplasm
4
2004
58
0.140
Why?
Tumor Virus Infections
1
1996
20
0.140
Why?
Estrogens
2
2007
162
0.130
Why?
Adult
14
2013
8391
0.130
Why?
Papillomavirus Infections
1
1996
52
0.130
Why?
Breast Neoplasms, Male
2
2006
11
0.120
Why?
Fallopian Tube Diseases
1
2013
6
0.110
Why?
Granulosa Cells
1
2013
11
0.110
Why?
Choristoma
1
2013
17
0.110
Why?
Fertility Agents, Female
2
2009
8
0.110
Why?
Diagnostic Errors
1
2013
42
0.110
Why?
Microsatellite Repeats
2
2004
25
0.110
Why?
Adenocarcinoma
2
2007
301
0.110
Why?
RNA, Messenger
5
2008
514
0.100
Why?
Receptors, Androgen
2
2002
39
0.100
Why?
Diagnosis, Differential
4
2003
493
0.100
Why?
Neoplasm Invasiveness
4
2016
189
0.100
Why?
Middle Aged
9
2007
10805
0.100
Why?
Menstrual Cycle
2
2008
36
0.090
Why?
Integrin beta3
2
2009
10
0.090
Why?
Aged
8
2007
9461
0.090
Why?
Aged, 80 and over
5
2006
3712
0.090
Why?
Keratins
2
1999
36
0.080
Why?
Uterine Diseases
1
2008
15
0.080
Why?
GATA3 Transcription Factor
1
2008
2
0.080
Why?
T-Box Domain Proteins
1
2008
12
0.080
Why?
Immediate-Early Proteins
1
2007
9
0.080
Why?
Breast
2
2004
53
0.070
Why?
Up-Regulation
2
2004
183
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2007
100
0.070
Why?
Cells, Cultured
2
2006
799
0.070
Why?
Selective Estrogen Receptor Modulators
1
2006
29
0.070
Why?
Gene Amplification
1
2005
9
0.070
Why?
In Situ Hybridization, Fluorescence
1
2005
37
0.070
Why?
Focal Adhesion Kinase 1
1
2004
3
0.070
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2004
3
0.070
Why?
Hysterectomy
2
2013
37
0.060
Why?
Tissue Array Analysis
1
2004
34
0.060
Why?
Tumor Suppressor Protein p53
1
2004
68
0.060
Why?
Neoplasm Staging
1
2005
436
0.060
Why?
Neoplasm Metastasis
3
2016
199
0.060
Why?
Nitroimidazoles
1
2003
4
0.060
Why?
Carcinoma
1
2004
87
0.060
Why?
Radiation-Sensitizing Agents
1
2003
15
0.060
Why?
Protein Precursors
1
2003
20
0.060
Why?
Immunohistochemistry
5
2007
519
0.060
Why?
Histiocytosis, Sinus
1
2003
3
0.060
Why?
Hemangiosarcoma
1
2003
8
0.060
Why?
Hemangioendothelioma
1
2003
11
0.060
Why?
Gene Expression Regulation
1
2006
481
0.060
Why?
Pregnancy
1
2006
807
0.060
Why?
Cell Differentiation
3
2003
436
0.050
Why?
Anovulation
1
2002
5
0.050
Why?
Ovulation Induction
1
2002
8
0.050
Why?
Receptors, Estrogen
1
2002
89
0.050
Why?
Adolescent
5
2009
3248
0.050
Why?
Transcription Factors
1
2002
172
0.050
Why?
Cell Transplantation
1
2001
63
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2000
13
0.050
Why?
Myocardium
1
2001
170
0.050
Why?
Ascites
1
2000
13
0.050
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1999
17
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2008
248
0.040
Why?
Stem Cell Transplantation
1
2001
203
0.040
Why?
Alleles
1
1999
251
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2000
249
0.040
Why?
Fibroblast Growth Factor 3
1
1998
1
0.040
Why?
Genes, p53
1
1998
23
0.040
Why?
Repressor Proteins
1
1998
53
0.040
Why?
Fibroblast Growth Factors
1
1998
34
0.040
Why?
Proto-Oncogene Proteins
1
1998
90
0.040
Why?
Tumor Suppressor Proteins
1
1998
72
0.040
Why?
Liver
1
2001
464
0.040
Why?
Uterine Hemorrhage
1
1997
7
0.040
Why?
Myometrium
1
1997
11
0.040
Why?
Risk Factors
2
1996
3509
0.040
Why?
Chromosome Aberrations
1
1997
21
0.040
Why?
Radiotherapy, Adjuvant
1
1997
68
0.040
Why?
Prognosis
2
2003
1362
0.040
Why?
Blood Vessels
1
1997
47
0.040
Why?
Chemotherapy, Adjuvant
1
1997
163
0.040
Why?
Ovariectomy
1
1997
147
0.040
Why?
Longitudinal Studies
1
1998
708
0.040
Why?
Follow-Up Studies
2
2003
2105
0.040
Why?
Gene Silencing
1
2016
49
0.030
Why?
Neoplasm Recurrence, Local
1
1998
337
0.030
Why?
Survival Rate
1
1997
795
0.030
Why?
Mice
2
2016
2368
0.030
Why?
Receptors, Cell Surface
1
1994
72
0.030
Why?
Estrogen Replacement Therapy
1
1994
182
0.030
Why?
Granulosa Cell Tumor
1
2013
1
0.030
Why?
Stromal Cells
2
2004
70
0.030
Why?
Leiomyoma
1
2013
16
0.030
Why?
Uterine Neoplasms
1
2013
23
0.030
Why?
Incidence
1
1996
1105
0.030
Why?
Epithelial Cells
2
2004
138
0.030
Why?
Male
6
2008
17767
0.030
Why?
Transcription, Genetic
2
2003
136
0.030
Why?
Genetic Markers
2
2004
122
0.030
Why?
Osteopontin
1
2009
9
0.020
Why?
Animals
2
2016
7296
0.020
Why?
Luteinizing Hormone
1
2008
18
0.020
Why?
Administration, Cutaneous
1
2008
107
0.020
Why?
Receptors, Progesterone
1
2008
45
0.020
Why?
Organ Size
1
2008
196
0.020
Why?
Cysteine-Rich Protein 61
1
2007
2
0.020
Why?
Phenotype
2
2000
629
0.020
Why?
Dose-Response Relationship, Drug
1
2008
641
0.020
Why?
Gene Expression
1
2008
332
0.020
Why?
Retrospective Studies
2
2007
3100
0.020
Why?
Genomic Instability
1
2004
3
0.020
Why?
Nucleic Acid Hybridization
1
2004
18
0.020
Why?
Cell Communication
1
2004
30
0.020
Why?
Metallothionein
1
2003
4
0.010
Why?
In Situ Hybridization
1
2003
35
0.010
Why?
Hemangioma, Cavernous
1
2003
3
0.010
Why?
Mammography
1
2003
37
0.010
Why?
Oxygen
1
2003
139
0.010
Why?
Thrombosis
1
2003
60
0.010
Why?
Nuclear Receptor Coactivator 2
1
2002
3
0.010
Why?
Nuclear Receptor Coactivator 3
1
2002
3
0.010
Why?
Nuclear Receptor Coactivator 1
1
2002
4
0.010
Why?
Micromanipulation
1
2002
2
0.010
Why?
RNA Probes
1
2002
4
0.010
Why?
Biopsy
1
2003
241
0.010
Why?
Histone Acetyltransferases
1
2002
5
0.010
Why?
Young Adult
1
2009
2398
0.010
Why?
Clomiphene
1
2002
5
0.010
Why?
Dissection
1
2002
16
0.010
Why?
Axilla
1
2002
15
0.010
Why?
Immunoenzyme Techniques
1
2002
46
0.010
Why?
Infertility
1
2002
13
0.010
Why?
RNA, Neoplasm
1
2002
20
0.010
Why?
Receptors, Vitronectin
1
2002
4
0.010
Why?
Calcinosis
1
2003
143
0.010
Why?
Androgens
1
2002
22
0.010
Why?
Reference Values
1
2002
224
0.010
Why?
beta-Galactosidase
1
2001
16
0.010
Why?
Cell Line, Tumor
1
2003
680
0.010
Why?
Cell Lineage
1
2001
67
0.010
Why?
Blotting, Western
1
2002
281
0.010
Why?
Rats, Inbred F344
1
2001
125
0.010
Why?
Luminescent Proteins
1
2000
24
0.010
Why?
Lactation
1
2000
14
0.010
Why?
Mice, Nude
1
2001
276
0.010
Why?
Green Fluorescent Proteins
1
2000
71
0.010
Why?
Tumor Cells, Cultured
1
2000
158
0.010
Why?
Child
1
2006
2209
0.010
Why?
Cell Line
1
2001
449
0.010
Why?
Recombinant Fusion Proteins
1
2000
97
0.010
Why?
Transfection
1
2000
192
0.010
Why?
Cell Nucleus
1
2000
105
0.010
Why?
Cell Division
1
1999
97
0.010
Why?
Lymphatic Metastasis
1
1998
156
0.010
Why?
Tomography, X-Ray Computed
1
2003
871
0.010
Why?
X Chromosome
1
1997
24
0.010
Why?
Metaplasia
1
1997
20
0.010
Why?
Heterozygote
1
1997
52
0.010
Why?
Prospective Studies
1
2002
2010
0.010
Why?
Rats
1
2001
1604
0.010
Why?
Treatment Outcome
1
2003
3094
0.010
Why?
Mutation
1
1997
466
0.010
Why?
Lininger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (203)
Explore
_
Co-Authors (1)
Explore
_
Same Department Expand Description
Explore
_